APO Research
Talk to an analyst

APO RESEARCH · REPORT

Wound Care Biologics

Wound Care Biologics is an evolving segment of the advanced wound care market, which includes enzyme based formulations, Biologic Skin Substitutes, xenografts and cell based biogens to promote wound healing.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Wound Care Biologics is an evolving segment of the advanced wound care market, which includes enzyme based formulations, Biologic Skin Substitutes, xenografts and cell based biogens to promote wound healing.

Wound care biologics are being frequently used to treat complex burn injuries in patients with the inadequate skin for grafting. Since then, wound care biologics have been established and used to treat the prevalent problem of most complex chronic wounds such as diabetic foot ulcer and venous leg ulcers.

Selected research

Market Outlook & Growth Opportunities

Global Wound Care Biologics Market Outlook and Growth Opportunities 2026

21 December 2025191 pages

Choose your research edition.

Industry ResearchWound Care Biologics Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Wound Care Biologics Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Wound Care Biologics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Wound Care Biologics Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Wound Care Biologics Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Wound Care Biologics is an evolving segment of the advanced wound care market, which includes enzyme based formulations, Biologic Skin Substitutes, xenografts and cell based biogens to promote wound healing.

Wound care biologics are being frequently used to treat complex burn injuries in patients with the inadequate skin for grafting. Since then, wound care biologics have been established and used to treat the prevalent problem of most complex chronic wounds such as diabetic foot ulcer and venous leg ulcers.

Global Wound Care Biologics key players include Smith and Nephew, Organogenesis, MiMedx, Integra, Osiris, etc. Global top five players hold a share about 35%.

Read the full market overview

North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, having a total share about 35 percent.

In terms of product, Biologic Skin Substitutes is the largest segment, with a share about 55%. And in terms of application, the largest application is Chronic Wounds, followed by Acute Wounds, Surgical Wounds.

This report provides an overview of the global Wound Care Biologics market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Wound Care Biologics and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Wound Care Biologics revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Wound Care Biologics market.

Wound Care Biologics Segment by Company

Smith and Nephew

Organogenesis

MiMedx

Integra

Osiris

Derma Sciences, Inc

Soluble Systems

Amnio Technology, LLC

Medline

Skye® Biologics

Alphatec Spine,Inc.

Pinnacle Transplant Technologies

Wound Care Biologics Segment by Type

Biologic Skin Substitutes

Enzyme Based Formulations

Growth Factors

Wound Care Biologics Segment by Application

Acute Wounds

Chronic Wounds

Surgical Wounds

Wound Care Biologics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Wound Care Biologics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Wound Care Biologics key companies, revenue, market share, and recent developments.

3. To split the Wound Care Biologics breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Wound Care Biologics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Wound Care Biologics significant trends, drivers, influence factors in global and regions.

6. To analyze Wound Care Biologics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Wound Care Biologics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Wound Care Biologics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Wound Care Biologics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Wound Care Biologics industry.

Chapter 3: Detailed analysis of Wound Care Biologics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Wound Care Biologics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Wound Care Biologics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Wound Care Biologics Industry Trends Table 2. Wound Care Biologics Industry Drivers Table 3. Wound Care Biologics Industry Opportunities and Challenges Table 4. Wound Care Biologics Industry Restraints Table 5. Global Wound Care Biologics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Wound Care Biologics Revenue Share by Company (2021-2026) Table 7. Global Wound Care Biologics Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Wound Care Biologics Key Company Manufacturing Base & Headquarters Table 9. Global Wound Care Biologics Company, Product Type & Application Table 10. Global Wound Care Biologics Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Wound Care Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Biologic Skin Substitutes Table 15. Significant Companies of Enzyme Based Formulations Table 16. Significant Companies of Growth Factors Table 17. Global Wound Care Biologics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Wound Care Biologics Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Wound Care Biologics Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Wound Care Biologics Sales Value Share by Type (2021-2026) Table 21. Global Wound Care Biologics Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Acute Wounds Table 23. Significant Companies of Chronic Wounds Table 24. Significant Companies of Surgical Wounds Table 25. Global Wound Care Biologics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Wound Care Biologics Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Wound Care Biologics Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Wound Care Biologics Sales Value Share by Application (2021-2026) Table 29. Global Wound Care Biologics Sales Value Share by Application (2027-2032) Table 30. Global Wound Care Biologics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Wound Care Biologics Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Wound Care Biologics Sales Value Share by Region (2021-2026) Table 33. Global Wound Care Biologics Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Wound Care Biologics Sales Value Share by Region (2027-2032) Table 35. Global Wound Care Biologics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Wound Care Biologics Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Wound Care Biologics Sales Value Market Share by Country (2021-2026) Table 38. Global Wound Care Biologics Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Wound Care Biologics Sales Value Market Share by Country (2027-2032) Table 40. Smith and Nephew Company Information Table 41. Smith and Nephew Business Overview Table 42. Smith and Nephew Wound Care Biologics Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Smith and Nephew Wound Care Biologics Product Portfolio Table 44. Smith and Nephew Recent Development Table 45. Organogenesis Company Information Table 46. Organogenesis Business Overview Table 47. Organogenesis Wound Care Biologics Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Organogenesis Wound Care Biologics Product Portfolio Table 49. Organogenesis Recent Development Table 50. MiMedx Company Information Table 51. MiMedx Business Overview Table 52. MiMedx Wound Care Biologics Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. MiMedx Wound Care Biologics Product Portfolio Table 54. MiMedx Recent Development Table 55. Integra Company Information Table 56. Integra Business Overview Table 57. Integra Wound Care Biologics Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Integra Wound Care Biologics Product Portfolio Table 59. Integra Recent Development Table 60. Osiris Company Information Table 61. Osiris Business Overview Table 62. Osiris Wound Care Biologics Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Osiris Wound Care Biologics Product Portfolio Table 64. Osiris Recent Development Table 65. Derma Sciences, Inc Company Information Table 66. Derma Sciences, Inc Business Overview Table 67. Derma Sciences, Inc Wound Care Biologics Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Derma Sciences, Inc Wound Care Biologics Product Portfolio Table 69. Derma Sciences, Inc Recent Development Table 70. Soluble Systems Company Information Table 71. Soluble Systems Business Overview Table 72. Soluble Systems Wound Care Biologics Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Soluble Systems Wound Care Biologics Product Portfolio Table 74. Soluble Systems Recent Development Table 75. Amnio Technology, LLC Company Information Table 76. Amnio Technology, LLC Business Overview Table 77. Amnio Technology, LLC Wound Care Biologics Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Amnio Technology, LLC Wound Care Biologics Product Portfolio Table 79. Amnio Technology, LLC Recent Development Table 80. Medline Company Information Table 81. Medline Business Overview Table 82. Medline Wound Care Biologics Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Medline Wound Care Biologics Product Portfolio Table 84. Medline Recent Development Table 85. Skye® Biologics Company Information Table 86. Skye® Biologics Business Overview Table 87. Skye® Biologics Wound Care Biologics Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Skye® Biologics Wound Care Biologics Product Portfolio Table 89. Skye® Biologics Recent Development Table 90. Alphatec Spine,Inc. Company Information Table 91. Alphatec Spine,Inc. Business Overview Table 92. Alphatec Spine,Inc. Wound Care Biologics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 93. Alphatec Spine,Inc. Wound Care Biologics Product Portfolio Table 94. Alphatec Spine,Inc. Recent Development Table 95. Pinnacle Transplant Technologies Company Information Table 96. Pinnacle Transplant Technologies Business Overview Table 97. Pinnacle Transplant Technologies Wound Care Biologics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 98. Pinnacle Transplant Technologies Wound Care Biologics Product Portfolio Table 99. Pinnacle Transplant Technologies Recent Development Table 100. Research Programs/Design for This Report Table 101. Authors List of This Report Table 102. Secondary Sources Table 103. Primary Sources List of Figures Figure 1. Wound Care Biologics Product Image Figure 2. Global Wound Care Biologics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Wound Care Biologics Market Size (2021-2032) & (US$ Million) Figure 4. Global Wound Care Biologics Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Biologic Skin Substitutes Image Figure 8. Enzyme Based Formulations Image Figure 9. Growth Factors Image Figure 10. Global Wound Care Biologics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Wound Care Biologics Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Wound Care Biologics Sales Value Share by Type (2021-2032) Figure 13. Acute Wounds Image Figure 14. Chronic Wounds Image Figure 15. Surgical Wounds Image Figure 16. Global Wound Care Biologics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Wound Care Biologics Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Wound Care Biologics Sales Value Share by Application (2021-2032) Figure 19. Global Wound Care Biologics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Wound Care Biologics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Wound Care Biologics Sales Value (2021-2032) & (US$ Million) Figure 22. North America Wound Care Biologics Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Wound Care Biologics Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Wound Care Biologics Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Wound Care Biologics Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Wound Care Biologics Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Wound Care Biologics Sales Value (2021-2032) & (US$ Million) Figure 28. South America Wound Care Biologics Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Wound Care Biologics Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Wound Care Biologics Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Wound Care Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Wound Care Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Wound Care Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Wound Care Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Wound Care Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Wound Care Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Wound Care Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Wound Care Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Wound Care Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Wound Care Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Wound Care Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Wound Care Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Wound Care Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Wound Care Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Wound Care Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Wound Care Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Wound Care Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Wound Care Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Wound Care Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Wound Care Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Wound Care Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Wound Care Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Wound Care Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Wound Care Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Wound Care Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Wound Care Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Wound Care Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Wound Care Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Wound Care Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Wound Care Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Wound Care Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Wound Care Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Wound Care Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Wound Care Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Wound Care Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Wound Care Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Wound Care Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Wound Care Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Wound Care Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Wound Care Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Wound Care Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Wound Care Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Wound Care Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Wound Care Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Wound Care Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Wound Care Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Wound Care Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Wound Care Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Wound Care Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Wound Care Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Wound Care Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Wound Care Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Wound Care Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Wound Care Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Wound Care Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Wound Care Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Wound Care Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Wound Care Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Wound Care Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Wound Care Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Wound Care Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Wound Care Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Wound Care Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Wound Care Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Wound Care Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Wound Care Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Wound Care Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Wound Care Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Wound Care Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Wound Care Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Wound Care Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Wound Care Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Wound Care Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Wound Care Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Wound Care Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Wound Care Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Wound Care Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Wound Care Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Wound Care Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Wound Care Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Wound Care Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Wound Care Biologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Wound Care Biologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Wound Care Biologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Biologic Skin Substitutes
  • Enzyme Based Formulations
  • Growth Factors
Applications
  • Acute Wounds
  • Chronic Wounds
  • Surgical Wounds
Companies covered
  • Smith and Nephew
  • Organogenesis
  • MiMedx
  • Integra
  • Osiris
  • Derma Sciences, Inc
  • Soluble Systems
  • Amnio Technology, LLC
  • Medline
  • Skye® Biologics
  • Alphatec Spine,Inc.
  • Pinnacle Transplant Technologies

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Wound Care Biologics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Wound Care Biologics Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Wound Care Biologics Market Dynamics
  1. 2.1 Wound Care Biologics Industry Trends
  2. 2.2 Wound Care Biologics Industry Drivers
  3. 2.3 Wound Care Biologics Industry Opportunities and Challenges
  4. 2.4 Wound Care Biologics Industry Restraints
3 Wound Care Biologics Market by Company
  1. 3.1 Global Wound Care Biologics Company Revenue Ranking in 2025
  2. 3.2 Global Wound Care Biologics Revenue by Company (2021-2026)
  3. 3.3 Global Wound Care Biologics Company Ranking (2024-2026)
  4. 3.4 Global Wound Care Biologics Company Manufacturing Base and Headquarters
  5. 3.5 Global Wound Care Biologics Company Product Type and Application
  6. 3.6 Global Wound Care Biologics Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Wound Care Biologics Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Wound Care Biologics Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Wound Care Biologics Market by Type
  1. 4.1 Wound Care Biologics Type Introduction
  2. 4.1.1 Biologic Skin Substitutes
  3. 4.1.2 Enzyme Based Formulations
  4. 4.1.3 Growth Factors
  5. 4.2 Global Wound Care Biologics Sales Value by Type
  6. 4.2.1 Global Wound Care Biologics Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Wound Care Biologics Sales Value by Type (2021-2032)
  8. 4.2.3 Global Wound Care Biologics Sales Value Share by Type (2021-2032)
5 Wound Care Biologics Market by Application
  1. 5.1 Wound Care Biologics Application Introduction
  2. 5.1.1 Acute Wounds
  3. 5.1.2 Chronic Wounds
  4. 5.1.3 Surgical Wounds
  5. 5.2 Global Wound Care Biologics Sales Value by Application
  6. 5.2.1 Global Wound Care Biologics Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Wound Care Biologics Sales Value by Application (2021-2032)
  8. 5.2.3 Global Wound Care Biologics Sales Value Share by Application (2021-2032)
6 Wound Care Biologics Regional Value Analysis
  1. 6.1 Global Wound Care Biologics Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Wound Care Biologics Sales Value by Region (2021-2032)
  3. 6.2.1 Global Wound Care Biologics Sales Value by Region: 2021-2026
  4. 6.2.2 Global Wound Care Biologics Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Wound Care Biologics Sales Value (2021-2032)
  7. 6.3.2 North America Wound Care Biologics Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Wound Care Biologics Sales Value (2021-2032)
  10. 6.4.2 Europe Wound Care Biologics Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Wound Care Biologics Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Wound Care Biologics Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Wound Care Biologics Sales Value (2021-2032)
  16. 6.6.2 South America Wound Care Biologics Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Wound Care Biologics Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Wound Care Biologics Sales Value Share by Country, 2025 VS 2032
7 Wound Care Biologics Country-level Value Analysis
  1. 7.1 Global Wound Care Biologics Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Wound Care Biologics Sales Value by Country (2021-2032)
  3. 7.2.1 Global Wound Care Biologics Sales Value by Country (2021-2026)
  4. 7.2.2 Global Wound Care Biologics Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Wound Care Biologics Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Wound Care Biologics Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Wound Care Biologics Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Wound Care Biologics Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Wound Care Biologics Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Wound Care Biologics Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Wound Care Biologics Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Wound Care Biologics Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Wound Care Biologics Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Wound Care Biologics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Wound Care Biologics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Wound Care Biologics Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Wound Care Biologics Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Wound Care Biologics Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Wound Care Biologics Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Wound Care Biologics Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Wound Care Biologics Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Wound Care Biologics Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Wound Care Biologics Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Wound Care Biologics Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Wound Care Biologics Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Wound Care Biologics Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Wound Care Biologics Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Wound Care Biologics Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Wound Care Biologics Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Wound Care Biologics Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Wound Care Biologics Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Wound Care Biologics Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Wound Care Biologics Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Wound Care Biologics Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Wound Care Biologics Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Wound Care Biologics Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Wound Care Biologics Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Wound Care Biologics Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Wound Care Biologics Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Wound Care Biologics Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Wound Care Biologics Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Wound Care Biologics Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Wound Care Biologics Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Wound Care Biologics Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Wound Care Biologics Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Wound Care Biologics Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Wound Care Biologics Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Wound Care Biologics Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Wound Care Biologics Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Wound Care Biologics Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Wound Care Biologics Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Wound Care Biologics Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Wound Care Biologics Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Wound Care Biologics Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Wound Care Biologics Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Wound Care Biologics Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Wound Care Biologics Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Wound Care Biologics Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Wound Care Biologics Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Wound Care Biologics Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Wound Care Biologics Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Wound Care Biologics Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Wound Care Biologics Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Wound Care Biologics Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Wound Care Biologics Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Wound Care Biologics Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Wound Care Biologics Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Wound Care Biologics Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Wound Care Biologics Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Wound Care Biologics Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Wound Care Biologics Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Wound Care Biologics Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Wound Care Biologics Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Wound Care Biologics Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Wound Care Biologics Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Wound Care Biologics Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Wound Care Biologics Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Wound Care Biologics Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Wound Care Biologics Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Wound Care Biologics Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Wound Care Biologics Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Wound Care Biologics Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Wound Care Biologics Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Wound Care Biologics Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Wound Care Biologics Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Wound Care Biologics Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Wound Care Biologics Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Wound Care Biologics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Smith and Nephew
  2. 8.1.1 Smith and Nephew Company Information
  3. 8.1.2 Smith and Nephew Business Overview
  4. 8.1.3 Smith and Nephew Wound Care Biologics Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Smith and Nephew Wound Care Biologics Product Portfolio
  6. 8.1.5 Smith and Nephew Recent Developments
  7. 8.2 Organogenesis
  8. 8.2.1 Organogenesis Company Information
  9. 8.2.2 Organogenesis Business Overview
  10. 8.2.3 Organogenesis Wound Care Biologics Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Organogenesis Wound Care Biologics Product Portfolio
  12. 8.2.5 Organogenesis Recent Developments
  13. 8.3 MiMedx
  14. 8.3.1 MiMedx Company Information
  15. 8.3.2 MiMedx Business Overview
  16. 8.3.3 MiMedx Wound Care Biologics Revenue and Gross Margin (2021-2026)
  17. 8.3.4 MiMedx Wound Care Biologics Product Portfolio
  18. 8.3.5 MiMedx Recent Developments
  19. 8.4 Integra
  20. 8.4.1 Integra Company Information
  21. 8.4.2 Integra Business Overview
  22. 8.4.3 Integra Wound Care Biologics Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Integra Wound Care Biologics Product Portfolio
  24. 8.4.5 Integra Recent Developments
  25. 8.5 Osiris
  26. 8.5.1 Osiris Company Information
  27. 8.5.2 Osiris Business Overview
  28. 8.5.3 Osiris Wound Care Biologics Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Osiris Wound Care Biologics Product Portfolio
  30. 8.5.5 Osiris Recent Developments
  31. 8.6 Derma Sciences, Inc
  32. 8.6.1 Derma Sciences, Inc Company Information
  33. 8.6.2 Derma Sciences, Inc Business Overview
  34. 8.6.3 Derma Sciences, Inc Wound Care Biologics Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Derma Sciences, Inc Wound Care Biologics Product Portfolio
  36. 8.6.5 Derma Sciences, Inc Recent Developments
  37. 8.7 Soluble Systems
  38. 8.7.1 Soluble Systems Company Information
  39. 8.7.2 Soluble Systems Business Overview
  40. 8.7.3 Soluble Systems Wound Care Biologics Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Soluble Systems Wound Care Biologics Product Portfolio
  42. 8.7.5 Soluble Systems Recent Developments
  43. 8.8 Amnio Technology, LLC
  44. 8.8.1 Amnio Technology, LLC Company Information
  45. 8.8.2 Amnio Technology, LLC Business Overview
  46. 8.8.3 Amnio Technology, LLC Wound Care Biologics Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Amnio Technology, LLC Wound Care Biologics Product Portfolio
  48. 8.8.5 Amnio Technology, LLC Recent Developments
  49. 8.9 Medline
  50. 8.9.1 Medline Company Information
  51. 8.9.2 Medline Business Overview
  52. 8.9.3 Medline Wound Care Biologics Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Medline Wound Care Biologics Product Portfolio
  54. 8.9.5 Medline Recent Developments
  55. 8.10 Skye® Biologics
  56. 8.10.1 Skye® Biologics Company Information
  57. 8.10.2 Skye® Biologics Business Overview
  58. 8.10.3 Skye® Biologics Wound Care Biologics Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Skye® Biologics Wound Care Biologics Product Portfolio
  60. 8.10.5 Skye® Biologics Recent Developments
  61. 8.11 Alphatec Spine,Inc.
  62. 8.11.1 Alphatec Spine,Inc. Company Information
  63. 8.11.2 Alphatec Spine,Inc. Business Overview
  64. 8.11.3 Alphatec Spine,Inc. Wound Care Biologics Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Alphatec Spine,Inc. Wound Care Biologics Product Portfolio
  66. 8.11.5 Alphatec Spine,Inc. Recent Developments
  67. 8.12 Pinnacle Transplant Technologies
  68. 8.12.1 Pinnacle Transplant Technologies Company Information
  69. 8.12.2 Pinnacle Transplant Technologies Business Overview
  70. 8.12.3 Pinnacle Transplant Technologies Wound Care Biologics Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Pinnacle Transplant Technologies Wound Care Biologics Product Portfolio
  72. 8.12.5 Pinnacle Transplant Technologies Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst